catalog number :
MBS619232
products full name :
a-Insulin Receptor, beta subunit (INSR, Insulin receptor)
products short name :
a-Insulin Receptor, beta subunit
products name syn :
Anti -a-Insulin Receptor, beta subunit (INSR, Insulin receptor)
reactivity :
Human, Mouse, Rat
specificity :
Recognizes human a-Insulin Receptor, beta subunit. Species Crossreactivity
purity :
Affinity Purified. Purified by immunoaffinity chromatography.
form :
Supplied as a liquid in 0.1M Tris-glycine, pH 7.4, 150mM sodium chloride, 0.05% sodium azide.
storage stability :
May be stored at 4 degree C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20 degree C. Aliquots are stable for at least 12 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
tested application :
Western Blot (WB), Immunoprecipitation (IP)
app notes :
Suitable for use in Western Blot and Immunoprecipitation. Dilution: Western Blot: 1:1000
other info1 :
Immunogen: GST-fusion protein corresponding to the last 100 C-terminal amino acid residues of the human insulin receptor beta chain.
other info2 :
Positive Control: Human brain tissue lysate
products categories :
Antibodies; Abs to Receptors
products description :
The insulin receptor is a tyrosine kinase receptor that when bound to insulin, initiates multiple signal transduction pathways, including JNK, PI 3-kinase, Akt and PKC. Pharmacological intervention of these Insulin R-dependent pathways is of great interest for the treatment of insulin resistance, obesity and diabetes. The Insulin Receptor (IR) is synthesized as a single polypeptide, which is subsequently cleaved to generate an extracellular alpha-chain and a transmembrane and intracellular beta-chain, tethered together by disulfide bonds. The beta-chain has multiple tyrosine phosphorylation sites, including three autophosphorylation sites at its activation loop. The overall structure of the IR is highly homologous to the IGF-I Receptor, except in their c-termini, where the two proteins diverge somewhat. The IR signals primarily by phosphorylating the Insulin Receptor Substrate (IRS) family of proteins, which creates docking sites for SH2-domain containing proteins. Insulin signaling is highly dependent on the PI3 Kinase pathway and Akt, which appear to mediate the functions of insulin.